Product image of Norditropin Flexpro (Somatropin) supplied by GNH India

Norditropin Flexpro

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin Flexpro, is a growth hormone presented as a solution for injection for subcutaneous use. It treats growth hormone deficiency in children and adults, Turner syndrome, chronic renal failure, and Prader‑Willi syndrome.

GNH India supplies Norditropin Flexpro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing rigorous quality standards, cold‑chain logistics, and a network that ensures timely access across multiple regions.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin Flexpro is used in growth hormone therapy to address conditions characterized by deficient endogenous growth hormone.

  • Growth hormone deficiency in children: promotes linear growth and improves height velocity.
  • Growth hormone deficiency in adults: helps normalize body composition and metabolic parameters.
  • Turner syndrome: supports growth and development in affected females.
  • Chronic renal failure: assists in growth promotion in pediatric patients with renal insufficiency.
  • Prader‑Willi syndrome: aids in improving body composition and growth.

How It Works

  • Somatropin mimics endogenous human growth hormone by binding to growth hormone receptors on target cells, activating the JAK2‑STAT5 signaling pathway. This stimulates hepatic production of insulin‑like growth factor‑1 (IGF‑1) and influences protein synthesis, lipolysis, and bone growth, resulting in anabolic and metabolic effects throughout the body. The increased IGF‑1 mediates many of the growth‑promoting actions, while direct GH signaling contributes to carbohydrate metabolism and muscle development.

Side Effects

Somatropin may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects

  • Injection site pain or erythema.
  • Headache.
  • Joint stiffness or arthralgia.
  • Peripheral edema.
  • Nausea.
  • Fatigue.

Serious or Rare Side Effects

  • Intracranial hypertension (headache, visual disturbances).
  • Slipped epiphysis (bone growth plate issues).
  • Glucose intolerance or new‑onset diabetes.
  • Severe allergic reactions, including anaphylaxis.
  • Tumor progression in patients with active malignancy.
  • Pancreatitis.

Precautions & Warnings

When prescribing somatropin, clinicians should consider several safety precautions to optimize benefit and minimize risk.

  • Monitor glucose levels: patients with diabetes may experience altered glycemic control.
  • Assess intracranial pressure: signs of headache or visual changes require evaluation.
  • Screen for malignancy: GH may accelerate tumor growth; avoid in active cancer.
  • Evaluate thyroid function: GH therapy can affect thyroid hormone levels.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Somatropin can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Glucocorticoids: high doses may blunt GH effect.
  • Oral estrogen: increases IGF‑1, may require dose adjustment.
  • Pegvisomant: GH receptor antagonist negates somatropin action.

Moderate Interactions (Monitor Closely)

  • Insulin: GH may increase insulin resistance; monitor glucose.
  • Oral hypoglycemics: dose may need adjustment.
  • Thyroid hormone replacement: GH can alter thyroid hormone levels; monitor TSH.
  • Diuretics: may exacerbate edema; observe fluid status.

Frequently Asked Questions

Norditropin Flexpro is a recombinant human growth hormone indicated for the treatment of growth hormone deficiency in children and adults, Turner syndrome, chronic renal failure‑related growth impairment, and Prader‑Willi syndrome. It helps promote linear growth, improve body composition, and support metabolic functions in these patient groups.

Somatropin mimics the body’s natural growth hormone by binding to growth hormone receptors, activating intracellular JAK2‑STAT5 signaling. This triggers the liver to produce insulin‑like growth factor‑1 (IGF‑1), which drives bone growth, protein synthesis, lipolysis, and other anabolic processes throughout the body.

The dose is individualized by the prescribing clinician based on factors such as the patient’s age, weight, severity of deficiency, and IGF‑1 response. Regular monitoring of growth parameters and IGF‑1 levels guides any necessary adjustments.

Safety in pregnancy and lactation has not been established. The product should only be used if the potential benefit justifies the potential risk to the fetus or infant, and it is generally avoided unless specifically recommended by a specialist.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and the necessary import documentation.

Norditropin Flexpro is a recombinant somatropin formulation delivered via a pre‑filled, flexible pen device, offering precise dosing and ease of use. Compared with vial‑and‑syringe products, the pen system reduces preparation steps and may improve patient adherence, while the active molecule is identical to other approved GH brands.

The product must be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Once in use, the pen can be kept at room temperature for a limited period as specified in the labeling, but any unused solution should be returned to refrigeration promptly.

Norditropin Flexpro is administered subcutaneously, typically into the thigh, abdomen or upper arm. The pre‑filled pen allows the prescriber to set the required dose, and patients are instructed to rotate injection sites to minimize local reactions.

Serious risks include intracranial hypertension, slipped epiphysis (growth‑plate fractures), worsening of glucose tolerance or diabetes, and potential acceleration of tumor growth in patients with active malignancy. Any signs of severe headache, visual changes, joint pain, or unexplained hyperglycemia should prompt immediate medical evaluation.

Norditropin Flexpro is contraindicated in individuals with known hypersensitivity to somatropin or any excipients, active malignancy, uncontrolled diabetes, or severe acute illness. Caution is also advised for patients with pre‑existing intracranial lesions or active proliferative retinopathy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT